FibroGen, Inc. (0IL8.L)

USD 0.25

(-14.21%)

Total Liabilities Summary of FibroGen, Inc.

  • FibroGen, Inc.'s latest annual total liabilities in 2023 was 585.72 Million USD , down -4.23% from previous year.
  • FibroGen, Inc.'s latest quarterly total liabilities in 2024 Q1 was 552.02 Million USD , down -5.75% from previous quarter.
  • FibroGen, Inc. reported annual total liabilities of 611.56 Million USD in 2022, up 12.27% from previous year.
  • FibroGen, Inc. reported annual total liabilities of 544.7 Million USD in 2021, up 41.34% from previous year.
  • FibroGen, Inc. reported quarterly total liabilities of 552.02 Million USD for 2024 Q1, down -5.75% from previous quarter.
  • FibroGen, Inc. reported quarterly total liabilities of 575.43 Million USD for 2023 Q2, up 1.41% from previous quarter.

Annual Total Liabilities Chart of FibroGen, Inc. (2023 - 2012)

Historical Annual Total Liabilities of FibroGen, Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 585.72 Million USD -4.23%
2022 611.56 Million USD 12.27%
2021 544.7 Million USD 41.34%
2020 385.39 Million USD 19.69%
2019 321.99 Million USD -8.56%
2018 352.12 Million USD 11.36%
2017 316.2 Million USD 7.39%
2016 294.44 Million USD 7.56%
2015 273.74 Million USD 12.72%
2014 242.85 Million USD 28.26%
2013 189.34 Million USD 32.04%
2012 143.4 Million USD 0.0%

Peer Total Liabilities Comparison of FibroGen, Inc.

Name Total Liabilities Total Liabilities Difference
uniQure N.V. 624.01 Million USD 6.136%
Agios Pharmaceuticals, Inc. 126.09 Million USD -364.499%
Amicus Therapeutics, Inc. 617.7 Million USD 5.177%
Atara Biotherapeutics, Inc. 264.73 Million USD -121.251%
bluebird bio, Inc. 424.62 Million USD -37.94%
Cara Therapeutics, Inc. 68.75 Million USD -751.856%
Imunon, Inc. 8.53 Million USD -6766.339%
Editas Medicine, Inc. 150.05 Million USD -290.34%
IQVIA Holdings Inc. 20.56 Billion USD 97.152%
Mettler-Toledo International Inc. 3.5 Billion USD 83.291%
Myriad Genetics, Inc. 312.9 Million USD -87.193%
Neurocrine Biosciences, Inc. 1.01 Billion USD 42.542%
Supernus Pharmaceuticals, Inc. 487.46 Million USD -20.159%
Verastem, Inc. 71.18 Million USD -722.825%
Walgreens Boots Alliance, Inc. 68.85 Billion USD 99.149%
Waters Corporation 3.47 Billion USD 83.152%
Thermo Fisher Scientific Inc. 51.88 Billion USD 98.871%
Biogen Inc. 12.04 Billion USD 95.137%
Nektar Therapeutics 267.04 Million USD -119.336%
Perrigo Company plc 6.04 Billion USD 90.304%
Dynavax Technologies Corporation 375.02 Million USD -56.184%
Illumina, Inc. 4.36 Billion USD 86.584%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD -1565.083%
Iovance Biotherapeutics, Inc. 195.73 Million USD -199.241%
Heron Therapeutics, Inc. 256.47 Million USD -128.373%
Unity Biotechnology, Inc. 37.29 Million USD -1470.653%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 69.01%
Sangamo Therapeutics, Inc. 82.43 Million USD -610.55%
Evolus, Inc. 209.68 Million USD -179.334%
Adicet Bio, Inc. 37.12 Million USD -1477.931%
Aclaris Therapeutics, Inc. 40.22 Million USD -1356.093%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 91.759%
Esperion Therapeutics, Inc. 660.79 Million USD 11.359%
Agilent Technologies, Inc. 4.91 Billion USD 88.09%
OPKO Health, Inc. 622.47 Million USD 5.904%
Homology Medicines, Inc. 118.53 Million USD -394.148%
Geron Corporation 146.12 Million USD -300.835%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 85.539%
Exelixis, Inc. 678.44 Million USD 13.666%
Viking Therapeutics, Inc. 20.07 Million USD -2818.28%
Anavex Life Sciences Corp. 12.53 Million USD -4573.113%
Intellia Therapeutics, Inc. 250.8 Million USD -133.536%
Zoetis Inc. 9.29 Billion USD 93.698%
Axsome Therapeutics, Inc. 397.25 Million USD -47.442%
Abeona Therapeutics Inc. 49.17 Million USD -1091.085%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 88.626%
Kala Pharmaceuticals, Inc. 48.44 Million USD -1109.058%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 77.501%
Sarepta Therapeutics, Inc. 2.4 Billion USD 75.648%
Corcept Therapeutics Incorporated 114.81 Million USD -410.163%
Halozyme Therapeutics, Inc. 1.64 Billion USD 64.49%
Blueprint Medicines Corporation 918.64 Million USD 36.24%
Insmed Incorporated 1.66 Billion USD 64.753%
TG Therapeutics, Inc. 169.08 Million USD -246.41%
Incyte Corporation 1.59 Billion USD 63.214%
Emergent BioSolutions Inc. 1.18 Billion USD 50.596%